Open AccessAutologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
Author(s) -
Esteban Enrique Elías,
María Belén Almejún,
Ana Colado,
Gregorio Cordini,
Maricef Vergara-Rubio,
Enrique Podaza,
Denise Risnik,
María Cabrejo,
Horacio Fernández-Grecco,
Raimundo F. Bezares,
Maria Del Rosario Custidiano,
Julio César Sánchez-Ávalos,
Ascensión Vicente,
Gonzalo Garate,
Mercedes Borge,
Mirta Giordano,
Romina Gamberale
Publication year - 2018
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2018.188680
Subject(s) - chronic lymphocytic leukemia , syk , cd20 , monoclonal antibody , medicine , immunology , cancer research , leukemia , antibody , tyrosine kinase , receptor